1 | EXAS | Exact Sciences Corporation | 3.23% |
2 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.17% |
3 | NBIX | Neurocrine Biosciences, Inc. | 2.97% |
4 | NTRA | Natera, Inc. | 2.88% |
5 | UTHR | United Therapeutics Corporation | 2.71% |
6 | INCY | Incyte Corporation | 2.55% |
7 | GILD | Gilead Sciences, Inc. | 2.53% |
8 | BPMC | Blueprint Medicines Corporation | 2.43% |
9 | INSM | Insmed Incorporated | 2.43% |
10 | EXEL | Exelixis, Inc. | 2.43% |
11 | BIIB | Biogen Inc. | 2.42% |
12 | VRTX | Vertex Pharmaceuticals Incorporated | 2.38% |
13 | AMGN | Amgen Inc. | 2.37% |
14 | ABBV | AbbVie Inc. | 2.32% |
15 | REGN | Regeneron Pharmaceuticals, Inc. | 2.32% |
16 | MRNA | Moderna, Inc. | 2.02% |
17 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.99% |
18 | BMRN | BioMarin Pharmaceutical Inc. | 1.86% |
19 | BBIO | BridgeBio Pharma, Inc. | 1.64% |
20 | TGTX | TG Therapeutics, Inc. | 1.57% |
21 | HALO | Halozyme Therapeutics, Inc. | 1.48% |
22 | RVMD | Revolution Medicines, Inc. | 1.48% |
23 | SMMT | Summit Therapeutics Inc. | 1.44% |
24 | IONS | Ionis Pharmaceuticals, Inc. | 1.44% |
25 | CRSP | CRISPR Therapeutics AG | 1.34% |
View XBI holdings |